New Therapeutic Area Leaders Extend PPD’s Drug Development Capabilities

PPD is adding significant therapeutic expertise in cardiovascular disease, critical care, endocrinology, metabolism and diabetes.

13 Dec. 2018

PPD Expands GMP Lab Testing Capabilities for Biologics

PPD is adding gene and cell therapy analytical testing to its GMP laboratory in Athlone, Ireland, to support the pharmaceutical industry’s growing need for biologics testing.

06 Dec. 2018

PPD® Laboratories’ Scientist Recognized as Rising Star

PPD announced that a scientist in the PPD® Laboratories biomarker lab in Richmond, Virginia, has received industry recognition for her bioanalysis expertise.

12 Nov. 2018

PPD Strengthens Drug Development Expertise with New Therapeutic Area Professionals

PPD has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience, hematology/oncology, rare diseases and pediatrics.

01 Nov. 2018

PPD Receives Medidata Accelerator Award for Clinical Trial Innovation

PPD has been honored by Medidata with its Medidata Accelerator Award, recognizing PPD’s commitment to innovation for advancing and accelerating the drug development process.

25 Oct. 2018

PPD Expands Central Labs’ Preclarus® Technology, Helping Clients Accelerate and Enhance Clinical Research Decision-making

PPD has expanded its central lab technology capabilities integrated with Preclarus®, the comprehensive data solution that consolidates and standardizes multisource data to give clients transparent, real-time access to clinical trial operations, as well as patient and lab data.

25 Jul. 2018

PPD Names Ron Garrow as Chief Human Resource Officer

PPD has named Ron Garrow executive vice president and chief human resource officer (CHRO).

24 Jul. 2018

Synexus Announces U.S.-Based Registry to Power Major Longitudinal Study on Brain Aging

Synexus announced a collaboration with the University of Exeter in the United Kingdom to launch one of the largest, registry-based research initiatives in the United States to help understand how healthy brains age.

23 Jul. 2018

Acurian and Synexus Launch SynexusPlus Enrollment-enhanced Site Solution

Acurian Inc. and Synexus have launched SynexusPlus, an integrated site solution for enrolling patients in clinical studies.

27 Jun. 2018

PPD’s PatientAdvantage Inverts Traditional Clinical Trial Delivery Method

PPD has introduced PatientAdvantage, a new patient enrollment model that significantly reduces the time and cost of conducting clinical trials for pharmaceutical and biotechnology customers.

25 Jun. 2018

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.